|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/28 | |
| A61P 35/00 | |||
| A61K 31/47 | |||
| A61K 31/337 | |||
| A61K 45/06 |
| (11) | Number of the document | 2296645 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09751682.7 |
| Date of filing the European patent application | 2009-05-22 | |
| (97) | Date of publication of the European application | 2011-03-23 |
| (45) | Date of publication and mention of the grant of the patent | 2014-11-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/045029 |
| Date | 2009-05-22 |
| (87) | Number | WO 2009/143454 |
| Date | 2009-11-26 |
| (30) | Number | Date | Country code |
| 55418 P | 2008-05-22 | US |
| (72) |
KEENE, Jeffery, L., US
RILEY, Dennis, P., US
BEARDSLEY, Robert, A., US
|
| (73) |
Galera Therapeutics, LLC,
101 Lindenwood Drive, Suite 405, Malvern, PA 19355,
US
|
| (54) | COMBINATION ANTITUMOR THERAPY |
| COMBINATION ANTITUMOR THERAPY |